XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Clinical trial NCT00127933 · COMPLETED
Trial details
- NCT number
- NCT00127933
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2009-04-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.